Interleukin-1 Receptor Antagonist as a Potential Mediator Linking Psoriasis and Non-Alcoholic Fatty Liver Disease: Insights From Mendelian Randomization and Experimental Evidence

Ce Shuai,&ast; Szeman Cheung,&ast; Li Zhang, Han Cao, Yongyong Yuan, Qinyi Ge, Youcong Wang, Xia Li, Jie Zheng, Feng Xue Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China&ast;These authors contr...

Full description

Bibliographic Details
Published in:	Clinical, Cosmetic and Investigational Dermatology
Main Authors:	Shuai C, Cheung S, Zhang L, Cao H, Yuan Y, Ge Q, Wang Y, Li X, Zheng J, Xue F
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-09-01
Subjects:	Psoriasis Non-alcoholic fatty liver disease Mendelian randomization Imiquimod-induced mouse model
Online Access:	https://www.dovepress.com/interleukin-1-receptor-antagonist-as-a-potential-mediator-linking-psor-peer-reviewed-fulltext-article-CCID

Similar Items

Association Between Psoriasis and Non-Alcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomization Study
by: Li H, et al.
Published: (2023-11-01)

Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model
by: Mehwish Jabeen, et al.
Published: (2020-08-01)

Distinct Impact of Phosphodiesterade-4 (PDE4) Inhibition in Two Pre-clinical Psoriasis Models
by: Sören Dräger, et al.
Published: (2025-04-01)

Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis
by: Junfeng Zhang, et al.
Published: (2023-03-01)

The effect of levofloxacin ointment against imiquimod induced–psoriasis in mice model
by: Waleed K. Al-Bahadly, et al.
Published: (2023-10-01)

Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals
by: Charlotte Näslund-Koch, et al.
Published: (2022-10-01)

Mupirocin blocks imiquimod-induced psoriasis-like skin lesion by inhibiting epidermal isoleucyl-tRNA synthetase
by: Bing-Xi Yan, et al.
Published: (2022-11-01)

Leptin deficiency mitigates cutaneous inflammation in a mouse model of psoriasis
by: Xinyan SHE, et al.
Published: (2023-02-01)

Causality of unsaturated fatty acids and psoriasis a Mendelian randomization study
by: Junchen Li, et al.
Published: (2024-02-01)

Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice
by: Ly Thi Huong Nguyen, et al.
Published: (2022-02-01)

A promising impact of oral administration of noscapine against imiquimod-induced psoriasis-like skin lesions
by: Fahimeh Nourbakhsh, et al.
Published: (2023-07-01)

Hydroxytyrosol ameliorates imiquimod-induced psoriasis-like dermatitis by modulating ERK and NF-κB signaling pathways in mice
by: Meng Liu, et al.
Published: (2025-08-01)

Effects Of Topical Petroleum Ether and Ethyl Acetate Fractions from Grape Seed Extract on Imiquimod-Induced Psoriasis Like Skin Inflammation in Mice
by: Mohammed Fareed, et al.
Published: (2024-04-01)

Brief Maternal Separation Promotes Resilience to Anxiety-like and Depressive-like Behaviors in Female C57BL/6J Offspring with Imiquimod-Induced Psoriasis
by: Lin Zhou, et al.
Published: (2022-09-01)

The Essential Oil Derived from <i>Perilla frutescens</i> (L.) Britt. Attenuates Imiquimod–Induced Psoriasis-like Skin Lesions in BALB/c Mice
by: Yani Xu, et al.
Published: (2022-05-01)

Amelioration of imiquimod-induced psoriasis-like dermatitis in mice by DSW therapy inspired hydrogel
by: Xiang He, et al.
Published: (2021-02-01)

Attenuated effects of topical vinpocetine in an imiquimod-induced mouse model of psoriasis
by: Hayder R. Salman, PhD, et al.
Published: (2024-02-01)

Combination Therapy of Acarbose and Cyclosporine a Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
by: Hsin-Hua Chen, et al.
Published: (2020-04-01)

Effect of 6-hydroxydopamine blockade of sympathetic nerves on systemic inflammation in an imiquimod-induced psoriasis-like mouse model
by: Siqi LIU, et al.
Published: (2022-06-01)

Silymarin exerts antipsoriatic effects against imiquimod-induced psoriasis in mice via NF-kB/TLR4 signaling pathway
by: Behnaz Azimi, et al.
Published: (2025-11-01)

Mume Fructus improves imiquimod-induced psoriasis-like dermatitis in mice
by: WANG Qing, et al.
Published: (2025-03-01)

Immunoproteasome inhibition attenuates experimental psoriasis
by: Marta del Rio Oliva, et al.
Published: (2022-12-01)

Human dental pulp stem cells ameliorate the imiquimod-induced psoriasis in mice
by: Kang Wen, et al.
Published: (2023-02-01)

Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice
by: Savannah D. Neu, et al.
Published: (2021-08-01)

Corrigendum: Immunoproteasome inhibition attenuates experimental psoriasis
by: Marta del Rio Oliva, et al.
Published: (2024-01-01)

Comparative study of anti-inflammatory activity of zinc pyrition on a psoriasis laboratory model
by: Alexander S. Zhukov, et al.
Published: (2020-08-01)

Platelets Aggregate With Neutrophils and Promote Skin Pathology in Psoriasis
by: Franziska Herster, et al.
Published: (2019-08-01)

Evaluation of the Effect of Topical Artemisia dracunculus Administration on Serum Levels of Selected Interleukins and Spleen Index in Imiquimod-Induced Psoriasis in Male Mice Compared to Clobetasol Propionate (Dermovate (R)) Ointment
by: Thamer M. Mohammed, et al.
Published: (2020-12-01)

Gain-of-function of TRPM4 predisposes mice to psoriasiform dermatitis
by: Daisuke Yamada, et al.
Published: (2022-10-01)

Coleus forskohlii shows anti-psoriatic activity in imiquimod-induced psoriasis rats
by: Sagarika Majhi, et al.
Published: (2024-09-01)

Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model
by: Zuzana Stehlikova, et al.
Published: (2019-02-01)

The Effect of Lenalidomide Ointment on TNF-α Tissue Levels in Mice with Imiquimod-Induced Psoriasis Effect of Lenalidomide Ointment on TNF-α Tissue Levels in Mice with Imiquimod-Induced Psoriasis.
by: sajjad Mustafa Thamer, et al.
Published: (2023-01-01)

Cladribine Ameliorates Imiquimod Induced Murine Psoriasiform Dermatitis
by: Xue J, et al.
Published: (2025-02-01)

Attenuated Effects of Topical Empagliflozin on Imiquimod-induced Model of Psoriasis in Mice
by: Alaa H. Abbas, et al.
Published: (2024-09-01)

Selenium nanoparticles produce a beneficial effect in psoriasis by reducing epidermal hyperproliferation and inflammation
by: Vinod Gangadevi, et al.
Published: (2021-04-01)

Ivermectin decreases inflammation and imiquimod–induced psoriasis-like skin lesions in rat via targeting TLR4 / p65 NF-κB
by: Tayebeh Noori, et al.
Published: (2025-06-01)

Lipid-Based Formulation of Baricitinib for the Topical Treatment of Psoriasis
by: Roya Mohammadi-Meyabadi, et al.
Published: (2024-09-01)

Causal association between arsenic metabolism and non-alcoholic fatty liver disease based on Mendelian randomization
by: Yuenan LIU, et al.
Published: (2023-12-01)

Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study
by: Yue Zhou, et al.
Published: (2023-12-01)

Association of depression with severe non-alcoholic fatty liver disease: evidence from the UK Biobank study and Mendelian randomization analysis
by: Xiaorui Zhou, et al.
Published: (2024-11-01)